HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER

被引：0
|
作者：
HEDLEY, D [1 ]
DALGLEISH, A [1 ]
COATES, A [1 ]
FOX, R [1 ]
RAGHAVAN, D [1 ]
TATTERSALL, M [1 ]
机构：
[1] LUDWIG INST CANC RES,SYDNEY CANC THERAPY BRANCH,SYDNEY,AUSTRALIA
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1983年 / 11卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [1] ADVANCED BREAST-CANCER - RESPONSE TO HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE
    HEDLEY, D
    DALGLEISH, A
    RAGHAVAN, D
    TATTERSALL, MHN
    COATES, A
    FOX, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1984, 14 (03): : 251 - 254
  • [2] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED MALE BREAST-CANCER
    PANNUTI, F
    MARTONI, A
    BUSUTTI, L
    GRAMELLINI, M
    PIANA, E
    CANCER TREATMENT REPORTS, 1982, 66 (09): : 1763 - 1765
  • [3] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE TREATMENT FOR RECURRENT BREAST-CANCER
    IINO, Y
    TAKEO, T
    SUGAMATA, N
    AOYAGI, H
    TAKAI, Y
    TAKEI, H
    ANDO, T
    KOIBUCHI, Y
    YOKOE, T
    OHWADA, S
    HORIGUCHI, J
    MORISHITA, Y
    ANTICANCER RESEARCH, 1995, 15 (03) : 1061 - 1064
  • [4] PHARMACOCLINICAL DATA ON HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    NAMER, M
    MILANO, G
    KHATER, R
    FRENAY, M
    THYSS, A
    RENEE, N
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (02) : 161 - 163
  • [5] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN COMBINATION WITH VINDESINE IN ADVANCED BREAST-CANCER
    FALKSON, HC
    FALKSON, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12): : 1511 - 1514
  • [6] ADRENAL SUPPRESSION BY ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    PRATT, JJ
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (02) : 83 - 86
  • [7] HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) TREATMENT IN ADVANCED BREAST-CANCER - REVIEW
    GANZINA, F
    TUMORI JOURNAL, 1979, 65 (05): : 563 - 585
  • [8] THE PHARMACOKINETICS OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN THE THERAPY OF ADVANCED BREAST-CANCER
    BLOSSEY, HC
    BARTSCH, HH
    KANNE, D
    KOEBBERLING, J
    NAGEL, GA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (01) : 77 - 81
  • [9] ORAL VERSUS IM ADMINISTRATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER
    BEEX, L
    BURGHOUTS, J
    VANTURNHOUT, J
    BREED, W
    HILLEN, H
    HOLDRINET, A
    BOETIUS, G
    HOOGENDOORN, G
    DOESBURG, W
    VERHULST, M
    MEULENBERG, P
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1151 - 1156
  • [10] HIGH-DOSE VERSUS LOW-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL
    GALLAGHER, CJ
    MCKINNA, JA
    CAIRNDUFF, F
    SMITH, IE
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 213 - 213
12345